STUCCI, LUIGIA STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 4.252
AS - Asia 1.483
EU - Europa 1.421
SA - Sud America 371
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 84
OC - Oceania 3
Totale 7.855
Nazione #
US - Stati Uniti d'America 4.111
SG - Singapore 579
IT - Italia 468
CN - Cina 335
BR - Brasile 285
SE - Svezia 194
RU - Federazione Russa 185
HK - Hong Kong 155
VN - Vietnam 133
DE - Germania 109
GB - Regno Unito 109
FR - Francia 97
FI - Finlandia 72
CA - Canada 68
IN - India 50
BD - Bangladesh 47
ID - Indonesia 31
UA - Ucraina 31
CI - Costa d'Avorio 29
NL - Olanda 29
AR - Argentina 28
BE - Belgio 23
TR - Turchia 20
ZA - Sudafrica 18
ES - Italia 17
IQ - Iraq 17
SA - Arabia Saudita 16
CO - Colombia 15
JP - Giappone 15
MX - Messico 15
IE - Irlanda 14
PL - Polonia 14
NP - Nepal 13
AT - Austria 11
CL - Cile 11
CR - Costa Rica 10
LT - Lituania 10
EC - Ecuador 9
PH - Filippine 9
HN - Honduras 8
MY - Malesia 8
NI - Nicaragua 8
PK - Pakistan 8
PY - Paraguay 8
VE - Venezuela 8
AL - Albania 7
GT - Guatemala 7
KE - Kenya 7
MA - Marocco 7
UZ - Uzbekistan 7
IL - Israele 6
JO - Giordania 6
KR - Corea 6
SV - El Salvador 6
TN - Tunisia 6
GR - Grecia 5
JM - Giamaica 5
RO - Romania 5
IR - Iran 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AU - Australia 3
BB - Barbados 3
BO - Bolivia 3
CH - Svizzera 3
CW - ???statistics.table.value.countryCode.CW??? 3
HU - Ungheria 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
KW - Kuwait 2
PR - Porto Rico 2
PT - Portogallo 2
SC - Seychelles 2
AM - Armenia 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MQ - Martinica 1
MR - Mauritania 1
MW - Malawi 1
NG - Nigeria 1
Totale 7.607
Città #
Ashburn 497
Fairfield 373
Singapore 330
Woodbridge 318
Chandler 301
San Jose 257
Houston 184
Seattle 163
Nyköping 159
Cambridge 149
Hong Kong 147
Milan 147
Beijing 131
Wilmington 126
Ann Arbor 116
New York 84
Los Angeles 79
Jacksonville 74
Council Bluffs 62
Dallas 55
Rome 55
Lauterbourg 53
Lawrence 49
Helsinki 47
Roxbury 47
Nanjing 46
Bari 45
Ho Chi Minh City 38
Munich 35
Des Moines 34
Santa Clara 33
Abidjan 29
Brooklyn 29
São Paulo 28
Inglewood 27
Brussels 22
Chicago 22
Princeton 22
Hanoi 21
London 21
Montreal 20
North Bergen 20
Paris 19
Buffalo 18
San Diego 18
Jakarta 17
Dong Ket 16
Boardman 15
Columbus 15
Denver 15
Nuremberg 15
Dublin 14
Poplar 14
Redwood City 13
Tokyo 13
Phoenix 12
Toronto 12
Atlanta 11
Chennai 11
Curitiba 11
Orem 11
Washington 11
Amsterdam 10
Figino 10
Frankfurt am Main 10
Stockholm 10
The Dalles 10
Warsaw 10
Dearborn 9
Kathmandu 9
Moscow 9
Nanchang 9
Belo Horizonte 8
Boston 8
Düsseldorf 8
Hebei 8
Johannesburg 8
Managua 8
Newark 8
Ottawa 8
Porto Alegre 8
San José 8
Santiago 8
Dhaka 7
Manchester 7
New Delhi 7
Palermo 7
San Francisco 7
Tashkent 7
Tianjin 7
Turin 7
Amman 6
Baghdad 6
Bologna 6
Da Nang 6
Hải Dương 6
Nairobi 6
Naples 6
Rio de Janeiro 6
San Mateo 6
Totale 5.070
Nome #
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 226
Adenocarcinoma of the ceruminous glands: role of the VMAT 205
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 204
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 197
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 192
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 192
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 190
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition 189
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 186
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 181
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 181
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 179
Double heterozygosity for BRCA1 pathogenic variant and BRCA2 polymorphic stop codon K3326X: A case report in a southern Italian family 177
Avβ3 integrin: Pathogenetic role in osteotropic tumors 177
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 171
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 167
Reframing Breast Cancer Experience through Metaphors: A New Operative System to Enhance Patients’ Healing Process 164
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 163
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 159
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice 159
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 158
Does cilengitide deserve another chance? 151
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 151
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 151
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 150
null 149
Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management 146
Current status and perspectives in immunotherapy for metastatic melanoma 143
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 140
COVID 19: HEALTH, STATISTICAL AND CONSTITUTIONAL ASPECTS 138
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma 135
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 127
miRNAs in melanoma: a defined role in tumor progression and metastasis 127
[Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease]. FT Alla ricerca di nuovi marcatori in osteo-oncologia: la fosfatasi acida tartrato-resistente nella malattia ossea mielomatosa 122
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 121
The immune escape in melanoma: role of the impaired dendritic cell function 118
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation 116
Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression? 115
Non-Melanoma Skin Cancers: Biological and Clinical Features 113
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery 112
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 112
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 109
A large metastatic intramammary lesion of an occult melanoma 107
Characterization of the metastatic behavior and gene expression profile (RNAseq) of different melanoma cell lines: a comprehensive in vivo model. 107
Dietary compounds and cutaneous malignant melanoma: Recent advances from a biological perspective 103
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice 98
Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: A potential role as additional prognostic marker 95
Effect of age on melanoma risk, prognosis and treatment response 94
Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: a potential role as additional prognostic marker. 84
null 78
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma. 76
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors 69
null 66
Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence? 65
null 62
null 57
Te avbeta3/avbeta5 blockage by Cilengitide disables the osteoclast-like differentiation of malignant plasma cells in multiple myeloma 51
Does clilengitide deserve another chance? 47
null 33
Totale 7.855
Categoria #
all - tutte 32.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022313 0 0 0 0 15 38 9 20 32 37 63 99
2022/2023727 106 98 46 70 69 100 14 85 107 7 15 10
2023/2024310 16 49 18 51 30 66 11 20 8 4 3 34
2024/20251.130 37 14 98 60 40 91 130 112 75 64 137 272
2025/20262.542 383 112 156 260 344 130 234 93 282 233 75 240
2026/2027597 76 95 128 264 34 0 0 0 0 0 0 0
Totale 7.855